Supplementary Table from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Table from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
Sallman DA. et al, (2023), J Clin Oncol
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis.
Mascarenhas J. et al, (2023), J Clin Oncol
cGAS-STING signalling in cancer: striking a balance with chromosomal instability.
Beernaert B. and Parkes EE., (2023), Biochem Soc Trans
Cytotoxic Chemotherapy for Pancreatic Adenocarcinoma in England 2010-2017: Survival Outcomes.
Wang Z. et al, (2023), Clin Oncol (R Coll Radiol)
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective.
Blagden SP. et al, (2023), Br J Cancer, 128, 474 - 477
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.
Jones R. et al, (2023), Clin Cancer Res, 29, 331 - 340
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Bannoud N. et al, (2023), Proc Natl Acad Sci U S A, 120
Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients.
Ryou H. et al, (2023), Leukemia
Association between epigenetic heterogeneity of esophageal adenocarcinoma and response to first-line immunochemotherapy in LUD2015-005 Trial
Xie PF. et al, (2023), CANCER RESEARCH, 83
CHROMOTHRIPSIS AND LEUKEMIC TRANSFORMATION IN MPN
Brierley C. et al, (2023), EXPERIMENTAL HEMATOLOGY, 124, S65 - S65
Chromothripsis Orchestrates Leukemic Transformation in Blast Phase MPN through Targetable Amplification of DYRK1A
Brierley CK. et al, (2023), BLOOD, 142
Investigating the effects of homologous recombination deficiency on radiotherapy response in pre-clinical prostate cancer
Kwon J. et al, (2023), EUROPEAN UROLOGY, 83
Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues
Reyat JS. et al, (2023), Frontiers in Cardiovascular Medicine, 10
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Marchetti M. et al, (2023), Ther Adv Hematol, 14
Phase I, first-in-human trial evaluating the STING agonist BI 1387446 alone and in combination with ezabenlimab in solid tumors
Calvo E. et al, (2023), ANNALS OF ONCOLOGY, 34, S626 - S626